The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
about
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adultsPitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan AfricaClinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionUpdate on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort studyTime for oncologists to opt in for routine opt-out HIV testing?Pathology of Kaposi's Sarcoma-Associated Herpesvirus InfectionA randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South AfricaAn overview of viral oncology in Italy - report from the Pavia meeting on solid tumors.HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS.Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this riskThe management of children with Kaposi sarcoma in resource limited settings.Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Predictors of immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: a case report.Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus.Rapid regression of Kaposi's sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy.Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx.HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015.Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study.Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives.
P2860
Q24193874-4FC6152F-DB4E-446C-B7FA-2038CD716930Q30386031-65B05C08-0F99-476E-AFCA-09674E26F186Q33442216-C3C3267E-1E06-44C5-9CEE-29040A9CEA2DQ33642284-E335751A-8DD5-49C1-B7DD-5B899A82418AQ34168712-A686E829-49E6-4DDC-9045-C839217E9376Q34765704-C105F907-8EA6-4B9B-A983-8D042EF628F5Q35178632-B80CCD14-47F3-4EBC-A011-A3745F9E482BQ35179783-C18A095D-D4E6-4E0B-B01A-54E6A6A048FBQ35989731-32E8AF49-1489-45C8-8069-5772BE4B0F9CQ36468756-15903853-A37E-4DCA-B4E5-7706990C9D82Q37250125-FBD4BF11-7C5A-4A1C-9E20-0E1BE180AE09Q37712406-E190EC6A-886E-4F58-84D7-3BEA8ED44323Q38068814-23025173-B4C2-4C74-9D53-0FB999490789Q38081246-D050904E-97D8-4A7E-A3F8-BFAE14DA69B7Q38194845-70B88EF3-2387-4005-B8F4-E94E7669A623Q38258034-9B923C07-70A9-4C62-BF4D-72E71DD6C0FBQ38848962-DEEC1C97-636C-460D-8CC4-9928C8B18453Q40747316-D632BC85-1C91-41E8-AB58-05381565BAD7Q40970345-FC899A12-7939-439F-9E07-CA6776E4F631Q41254170-04A9545B-4054-4080-A9B8-96DAC8B1C8BCQ44273355-4247136A-EFAA-46E1-8D26-AD64EFEB5894Q49232494-FA3AE4F4-68E6-439B-AE6D-0FCD69F8E03FQ53068032-48410B7E-6EAD-45E9-891C-04D4790246E6Q53686620-A4EAEFAC-53E7-4607-98B4-AD6B4E83A139
P2860
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@ast
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@en
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@nl
type
label
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@ast
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@en
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@nl
prefLabel
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@ast
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@en
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@nl
P2093
P1433
P1476
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
@en
P2093
Brian Gazzard
Justin Weir
Mark Bower
Mark Nelson
Marta Boffito
Nicholas Francis
Sam Powles
Tom Newsom-Davis
P304
P356
10.1097/QAD.0B013E32832D080D
P407
P577
2009-08-01T00:00:00Z